Envista Holdings Corp (STU:0HV)
€ 21 0 (0%) Market Cap: 3.63 Bil Enterprise Value: 4.18 Bil PE Ratio: 0 PB Ratio: 1.25 GF Score: 73/100

Envista Holdings Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 10, 2022 / 08:00PM GMT
Release Date Price: €38.85 (-0.38%)
Amir Aghdaei
Envista Holdings Corporation - President, CEO & Director

Thank you for inviting us. I'm sorry, go ahead, Rachel.

Unidentified Analyst

No, I was saying good afternoon, everyone. But thank you. This is Rachel (inaudible) from the Life Science Tools and Diagnostics team here at JPMorgan. I'd like to introduce Envista. (Operator Instructions)

So with that, let me turn it over to Amir.

Amir Aghdaei
Envista Holdings Corporation - President, CEO & Director

Thank you, Rachel. Thanks for inviting us. Going to follow sort of all sort of slides in here, I'm just going to refer to the number. So hopefully, we can say on it. So September 18, 2019 was the beginning the formation of Envista dental company that is purely geared to helping professional to improve people's lives. Since then, has a tremendous amount of changes has taken place in the industry.

But to begin with, I want to talk about the dental market. Back in March and April of 2019, 2020, there were a lot of negative views toward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot